Potential utility of 18F-NaF PET/CT in cardiac amyloidosis
Potential utility of 18F-NaF PET/CT in cardiac amyloidosis
复制标题
18F-NaF PET/CT 在心脏淀粉样变性中的潜在用途
DOI：
10.1007/s12350-021-02585-y
复制
发表时间：
2021
影响因子：
2.4
通讯作者：
Nishiyama Yoshihiro
中科院分区：
文献类型：
--
作者：
Tani Yuki;Norikane Takashi;Takami Yasukage;Mitamura Katsuya;Yamamoto Yuka;Morimoto Masatoshi;Noma Takahisa;Nishiyama Yoshihiro
心脏淀粉样变性(CA)的特征是不溶的错误折叠蛋白在心肌中沉积。CA根据在心肌中积累的蛋白质类型进行分类，主要有两种亚型：转甲状腺素(Attr)CA和轻链(AL)CA。近年来，用18F-氟化钠(18F-NaF)正电子发射断层扫描(PET)评价ATTRCA已引起人们的兴趣。1、2
Cardiac amyloidosis (CA) is characterized by the deposition of insoluble misfolded proteins in the myocardium. CA is classified based on the type of protein accumulating in the myocardium with two main recognized subtypes: transthyretin (ATTR) CA and light-chain (AL) CA. Recently, there has been emerging interest in using 18F-sodium fluoride (18F-NaF) positron emission tomography (PET) to evaluate ATTR CA. 1, 2
心脏淀粉样变性的病因学是否决定[18F]-NaF PET/CT 的心肌摄取？
影响因子：
2.4
作者：
C. Gagliardi;E. Tabacchi;R. Bonfiglioli;S. Diodato;C. Nanni;P. Guidalotti;Massimiliano Lorenzini;F. Lodi;A. Milandri;C. Rapezzi;S. Fanti
通讯作者：
S. Fanti